The evolution of antigen specific cancer immunotherapy from adoptive cell therapy to personalized cancer vaccines.
Research interest in antigen-based cancer immunotherapy remains robust and steady, with sustained annual publication suggesting active clinical development.
This study systematically analyzed the literature on tumor antigen-based cancer immunotherapy by integrating quantitative bibliometric analysis with knowledge network visualization. Bibliometric analysis showed that annual publication output in this field has remained relatively stable over the past six years, with approximately 170 publications per year and a peak of 188 publications in 2021.
What the study was
- Study design
- Observational study
- Category
- Treatment Innovation
- Maturity
- Validated
- Journal
- Discover oncology
Why it surfaced
Design: Observational study; Topics: Novel therapeutics: immunotherapy, CAR-T, targeted therapy; Species: human. Score=6/10.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.